首页> 美国卫生研究院文献>Saudi Pharmaceutical Journal : SPJ >Synthesis characterization and evaluation of deacetylated xanthan derivatives as new excipients in the formulation of chitosan-based polyelectrolytes for the sustained release of tramadol
【2h】

Synthesis characterization and evaluation of deacetylated xanthan derivatives as new excipients in the formulation of chitosan-based polyelectrolytes for the sustained release of tramadol

机译:脱乙酰基黄原衍生物的合成表征和评价作为壳聚糖基聚电解质持续释放曲马多的新赋形剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This paper addressed the application of deacetylated xanthan (XGDS) and chitosan (CTS) as a mixture blend forming hydrophilic matrices for Tramadol (TD) sustained release tablets. XGDSs derivatives were obtained by alkaline treatment of xanthan gum (XG) with various degrees of deacetylation (DD). The obtained products were characterized in terms of structural, thermal and physicochemical properties. Different tablet formulations containing CTS/XGDSs were prepared by direct compression method and compared to CTS/XG tablets. Flow properties of powder mixtures and pharmaceutical characteristics were evaluated. The dissolution test of TD was realized under simulated gastric and intestinal conditions to achieve drug release more than 24 h. All developed tablets were found conforming to standard evaluation tests. It was shown that CTS/XGDSs matrices ensure a slower release of TD in comparison with CTS/XG based formulations. Meanwhile, increasing DD resulted in a decrease of drug release. In addition, TD release from XGDS matrices was faster at pH (6.8) than at acidic pH (1.2). The matrix tablets based on CTS/XGDS4 (DD = 98.08%) were selected as the best candidates compared to the other systems in prolonging drug release. The optimal formulation was found to release 99.99% of TD after 24 h following a non-Fickian type.
机译:本文探讨了脱乙酰黄原胶(XGDS)和壳聚糖(CTS)作为形成亲水基质的曲马多(TD)缓释片剂的混合物混合物的应用。 XGDSs衍生物是通过对黄原胶(XG)进行不同程度的脱乙酰化(DD)碱性处理而获得的。根据结构,热和理化性质对所得产物进行表征。通过直接压片方法制备了含有CTS / XGDSs的不同片剂,并与CTS / XG片剂进行了比较。评估了粉末混合物的流动特性和药物特性。 TD的溶出度试验是在模拟的胃和肠条件下进行的,以实现24小时以上的药物释放。发现所有开发的片剂均符合标准评估测试。结果表明,与基于CTS / XG的制剂相比,CTS / XGDSs基质可确保TD的缓慢释放。同时,DD增加导致药物释放减少。另外,在pH(6.8)时,从XGDS基质释放的TD比在酸性pH(1.2)时更快。在延长药物释放方面,与其他系统相比,基于CTS / XGDS4(DD == 98.08%)的基质片剂被选为最佳候选药物。发现非Fickian型的最佳配方在24小时后释放99.99%的TD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号